Taiwan FDA registration 926672b36bfe8bc5133c68633856e9ed
Emanutec insulin precursor C-Shengxi reagent
TW: 伊曼紐特克胰島素前質C-胜呔試劑
Taiwan·Risk Class 2·IMMUNOTECH S.R.O.·Registered Sep 21, 2022 – Sep 21, 2027ActiveRegistration details
- Analysis ID
- 926672b36bfe8bc5133c68633856e9ed
- Customs Code
- DHAS5603585407
Company information
- Manufacturer
- IMMUNOTECH S.R.O.
- Manufacturer Country
- Czechia
- Authorized Representative
- MEGA BONA INTERNATIONAL CO., LTD.
Product details
- Intended Use
- This product is used by extracorporeal radiation immunoassay to determine the insulin precursor C-Shengxin in human serum and plasma.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1135 胰島素前質C-肽類試驗系統
- Import Information
- Consent must be attached to the import (with the consent of the Atomic Energy Commission must be obtained for each import); QMS/QSD;; input
Dates and status
- Registration Date
- Sep 21, 2022
- Expiry Date
- Sep 21, 2027
About this record
Access comprehensive regulatory information for Emanutec insulin precursor C-Shengxi reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 926672b36bfe8bc5133c68633856e9ed and manufactured by IMMUNOTECH S.R.O.. The authorized representative in Taiwan is MEGA BONA INTERNATIONAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices